Natalia joined Signet in 2020 as Investment Director taking part in managing and developing growing portfolio of healthcare investments in both private and public companies. She has extensive experience in deal sourcing, due diligence, valuation, and execution of life sciences investment opportunities as well as in managing and developing portfolios of biotechnology companies at various stages of development.
Prior to Signet, from 2017 Natalia focused on early-stage private life sciences companies in Europe working within entrepreneurial biotech ecosystem in Europe with academic start-ups and technology transfer offices and contributing to early-stage investment rounds. She also founded and actively fund raised for a seed fund dedicated to building early-stage life sciences ventures.
Prior to healthcare investing, Natalia was a Director at UBS Investment Bank from 2015 where she led structured financing transactions for institutional investors. Her expertise spans various financial products and asset classes with focus on global emerging markets. Her clients include extensive network of European institutional investors such as pension funds, hedge funds and real money asset managers. Natalia started her career in investment banking at Citi in London in 2009 on analyst graduate program and worked in Capital Markets Origination and Global Markets divisions moving on to VTB Capital in 2012.
Natalia holds a BSc in Biochemistry from Imperial College London, MSc Management with a focus on pharmaceutical industry from London School of Economics, and an MEng in Food Technology Engineering from Moscow State University of Applied Biotechnology.
Natalia is fluent in English, Russian, Italian, French and speaks conversational German.